Suppr超能文献

miR-150-5p通过靶向HMGA2和β-连环蛋白信号通路抑制非小细胞肺癌的转移和复发。

miR-150-5p Inhibits Non-Small-Cell Lung Cancer Metastasis and Recurrence by Targeting HMGA2 and β-Catenin Signaling.

作者信息

Dai Fu-Qiang, Li Cheng-Run, Fan Xiao-Qing, Tan Long, Wang Ren-Tao, Jin Hua

机构信息

Department of Thoracic Surgery, Daping Hospital and Research Institute of Surgery, Third Military Medical University, Chongqing 400042, China.

Department of Thoracic Surgery, The General Hospital of Chinese People's Liberation Army, Beijing 100853, China.

出版信息

Mol Ther Nucleic Acids. 2019 Jun 7;16:675-685. doi: 10.1016/j.omtn.2019.04.017. Epub 2019 Apr 23.

Abstract

Dysregulated microRNAs (miRNAs) play crucial roles in the regulation of cancer stem cells (CSCs), and CSCs are closely associated with tumor initiation, metastasis, and recurrence. Here we found that miR-150-5p was significantly downregulated in CSCs of non-small-cell lung cancer (NSCLC) and its expression level was negatively correlated with disease progression and poor survival in patients with NSCLC. Inhibition of miR-150-5p increased the CSC population and sphere formation of NSCLC cells in vitro and stimulated NSCLC cell tumorigenicity and metastatic colonization in vivo. In contrast, miR-150-5p overexpression potently inhibited sphere-formed NSCLC cell tumor formation, metastatic colonization, and recurrence in xenograft models. Furthermore, we identified that miR-150-5p significantly inhibited wingless (Wnt)-β-catenin signaling by simultaneously targeting glycogen synthase kinase 3 beta interacting protein (GSKIP) and β-catenin in NSCLC cells. miR-150-5p also targeted high mobility group AT-hook 2 (HMGA2), another regulator of CSCs, and Wnt-β-catenin signaling. The restoration of HMGA2 and β-catenin blocked miR-150-5p overexpression-induced inhibition of CSC traits in NSCLC cells. These findings suggest that miR-150-5p functions as a CSC suppressor and that overexpression of miR-150-5p may be a novel strategy to inhibit CSC-induced metastasis and recurrence in NSCLC.

摘要

失调的微小RNA(miRNA)在癌症干细胞(CSC)的调控中发挥着关键作用,且CSC与肿瘤的起始、转移和复发密切相关。在此,我们发现miR-150-5p在非小细胞肺癌(NSCLC)的CSC中显著下调,其表达水平与NSCLC患者的疾病进展和不良生存呈负相关。抑制miR-150-5p可增加NSCLC细胞在体外的CSC群体和球状体形成,并在体内刺激NSCLC细胞的致瘤性和转移定植。相反,在异种移植模型中,miR-150-5p过表达有力地抑制了形成球状体的NSCLC细胞的肿瘤形成、转移定植和复发。此外,我们确定miR-150-5p通过同时靶向NSCLC细胞中的糖原合酶激酶3β相互作用蛋白(GSKIP)和β-连环蛋白,显著抑制无翅型(Wnt)-β-连环蛋白信号通路。miR-150-5p还靶向CSC的另一个调节因子高迁移率族AT钩蛋白2(HMGA2)以及Wnt-β-连环蛋白信号通路。HMGA2和β-连环蛋白的恢复阻断了miR-150-5p过表达诱导的NSCLC细胞CSC特性抑制。这些发现表明,miR-150-5p作为一种CSC抑制因子发挥作用,miR-150-5p的过表达可能是抑制NSCLC中CSC诱导的转移和复发的一种新策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c062/6529773/448f6a7892e6/gr1.jpg

相似文献

1
miR-150-5p Inhibits Non-Small-Cell Lung Cancer Metastasis and Recurrence by Targeting HMGA2 and β-Catenin Signaling.
Mol Ther Nucleic Acids. 2019 Jun 7;16:675-685. doi: 10.1016/j.omtn.2019.04.017. Epub 2019 Apr 23.
2
Downregulation of DNMT3A by miR-708-5p Inhibits Lung Cancer Stem Cell-like Phenotypes through Repressing Wnt/β-catenin Signaling.
Clin Cancer Res. 2018 Apr 1;24(7):1748-1760. doi: 10.1158/1078-0432.CCR-17-1169. Epub 2017 Sep 28.
3
miR-135b Stimulates Osteosarcoma Recurrence and Lung Metastasis via Notch and Wnt/β-Catenin Signaling.
Mol Ther Nucleic Acids. 2017 Sep 15;8:111-122. doi: 10.1016/j.omtn.2017.06.008. Epub 2017 Jun 15.
4
LncRNA DGCR5 contributes to CSC-like properties via modulating miR-330-5p/CD44 in NSCLC.
J Cell Physiol. 2018 Sep;233(9):7447-7456. doi: 10.1002/jcp.26590. Epub 2018 Apr 16.
6
Epigallocatechin-3-gallate inhibited cancer stem cell-like properties by targeting hsa-mir-485-5p/RXRα in lung cancer.
J Cell Biochem. 2018 Nov;119(10):8623-8635. doi: 10.1002/jcb.27117. Epub 2018 Jul 30.
7
miR-512-5p suppresses the progression of non-small cell lung cancer by targeting β-catenin.
Oncol Lett. 2020 Jan;19(1):415-423. doi: 10.3892/ol.2019.11102. Epub 2019 Nov 14.
9
Role of MiR-3619-5p in β-Catenin-Mediated Non-Small Cell Lung Cancer Growth and Invasion.
Cell Physiol Biochem. 2015;37(4):1527-36. doi: 10.1159/000438520. Epub 2015 Oct 30.

引用本文的文献

3
The NcRNA/Wnt axis in lung cancer: oncogenic mechanisms, remarkable indicators and therapeutic targets.
J Transl Med. 2025 Mar 14;23(1):326. doi: 10.1186/s12967-025-06326-4.
6
Tankyrase 2 promotes lung cancer cell malignancy.
World J Clin Oncol. 2024 Jun 24;15(6):755-764. doi: 10.5306/wjco.v15.i6.755.
7
CMYC-initiated HNF1A-AS1 overexpression maintains the stemness of gastric cancer cells.
Cell Death Dis. 2024 Apr 23;15(4):288. doi: 10.1038/s41419-024-06673-y.
8
Blockade of the deubiquitinating enzyme USP48 degrades oncogenic HMGA2 and inhibits colorectal cancer invasion and metastasis.
Acta Pharm Sin B. 2024 Apr;14(4):1624-1643. doi: 10.1016/j.apsb.2024.01.006. Epub 2024 Jan 17.
9
HMGA2 promotes cancer metastasis by regulating epithelial-mesenchymal transition.
Front Oncol. 2024 Feb 1;14:1320887. doi: 10.3389/fonc.2024.1320887. eCollection 2024.
10
Sex differences in the tumor promoting effects of tobacco smoke in a cRaf transgenic lung cancer disease model.
Arch Toxicol. 2024 Mar;98(3):957-983. doi: 10.1007/s00204-023-03671-5. Epub 2024 Jan 21.

本文引用的文献

1
Lung cancer stem cells: origin, features, maintenance mechanisms and therapeutic targeting.
Biochem Pharmacol. 2019 Feb;160:121-133. doi: 10.1016/j.bcp.2018.12.010. Epub 2018 Dec 14.
2
suppresses triple-negative breast cancer metastasis through targeting HMGA2.
Onco Targets Ther. 2018 Apr 24;11:2319-2332. doi: 10.2147/OTT.S161996. eCollection 2018.
3
HMGA2 overexpression predicts relapse susceptibility of blastemal Wilms tumor patients.
Oncotarget. 2017 Dec 14;8(70):115290-115303. doi: 10.18632/oncotarget.23256. eCollection 2017 Dec 29.
4
miR-135b Stimulates Osteosarcoma Recurrence and Lung Metastasis via Notch and Wnt/β-Catenin Signaling.
Mol Ther Nucleic Acids. 2017 Sep 15;8:111-122. doi: 10.1016/j.omtn.2017.06.008. Epub 2017 Jun 15.
6
HMGA2 regulates lung cancer proliferation and metastasis.
Thorac Cancer. 2017 Sep;8(5):501-510. doi: 10.1111/1759-7714.12476. Epub 2017 Jul 28.
8
NOTCH1 Signaling Regulates Self-Renewal and Platinum Chemoresistance of Cancer Stem-like Cells in Human Non-Small Cell Lung Cancer.
Cancer Res. 2017 Jun 1;77(11):3082-3091. doi: 10.1158/0008-5472.CAN-16-1633. Epub 2017 Apr 17.
9
miR-150 Suppresses the Proliferation and Tumorigenicity of Leukemia Stem Cells by Targeting the Nanog Signaling Pathway.
Front Pharmacol. 2016 Nov 18;7:439. doi: 10.3389/fphar.2016.00439. eCollection 2016.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验